148 related articles for article (PubMed ID: 17300933)
21. Inhibitors of hepatitis C virus polymerase: synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl-benzothiadiazines.
Wagner R; Larson DP; Beno DW; Bosse TD; Darbyshire JF; Gao Y; Gates BD; He W; Henry RF; Hernandez LE; Hutchinson DK; Jiang WW; Kati WM; Klein LL; Koev G; Kohlbrenner W; Krueger AC; Liu J; Liu Y; Long MA; Maring CJ; Masse SV; Middleton T; Montgomery DA; Pratt JK; Stuart P; Molla A; Kempf DJ
J Med Chem; 2009 Mar; 52(6):1659-69. PubMed ID: 19226162
[TBL] [Abstract][Full Text] [Related]
22. Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 cells.
Beaulieu PL; Bousquet Y; Gauthier J; Gillard J; Marquis M; McKercher G; Pellerin C; Valois S; Kukolj G
J Med Chem; 2004 Dec; 47(27):6884-92. PubMed ID: 15615537
[TBL] [Abstract][Full Text] [Related]
23. 2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymerase.
Küçükgüzel I; Satılmış G; Gurukumar KR; Basu A; Tatar E; Nichols DB; Talele TT; Kaushik-Basu N
Eur J Med Chem; 2013 Nov; 69():931-41. PubMed ID: 24161679
[TBL] [Abstract][Full Text] [Related]
24. An efficient, asymmetric solid-phase synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.
Evans KA; Chai D; Graybill TL; Burton G; Sarisky RT; Lin-Goerke J; Johnston VK; Rivero RA
Bioorg Med Chem Lett; 2006 Apr; 16(8):2205-8. PubMed ID: 16455253
[TBL] [Abstract][Full Text] [Related]
25. Insight into the structural requirements of benzothiadiazine scaffold-based derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics.
Zhang HX; Li Y; Wang X; Xiao ZT; Wang YH
Curr Med Chem; 2011; 18(26):4019-28. PubMed ID: 21824089
[TBL] [Abstract][Full Text] [Related]
26. Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives.
Rawal RK; Katti SB; Kaushik-Basu N; Arora P; Pan Z
Bioorg Med Chem Lett; 2008 Dec; 18(23):6110-4. PubMed ID: 18947995
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of inhibitory effects of thiobarbituric acid derivatives targeting HCV NS5B polymerase.
Lee JH; Lee S; Park MY; Ha HJ; Myung H
J Microbiol Biotechnol; 2010 Mar; 20(3):510-2. PubMed ID: 20372020
[TBL] [Abstract][Full Text] [Related]
28. Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK properties.
Sergeeva MV; Zhou Y; Bartkowski DM; Nolan TG; Norris DA; Okamoto E; Kirkovsky L; Kamran R; Lebrun LA; Tsan M; Patel R; Shah AM; Lardy M; Gobbi A; Li LS; Zhao J; Bertolini T; Stankovic N; Sun Z; Murphy DE; Webber SE; Dragovich PS
Bioorg Med Chem Lett; 2008 Jun; 18(11):3421-6. PubMed ID: 18442904
[TBL] [Abstract][Full Text] [Related]
29. Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.
Ruebsam F; Sun Z; Ayida BK; Webber SE; Zhou Y; Zhao Q; Kissinger CR; Showalter RE; Shah AM; Tsan M; Patel R; Lebrun LA; Kamran R; Sergeeva MV; Bartkowski DM; Nolan TG; Norris DA; Kirkovsky L
Bioorg Med Chem Lett; 2008 Sep; 18(18):5002-5. PubMed ID: 18722768
[TBL] [Abstract][Full Text] [Related]
30. 3-heterocyclyl quinolone inhibitors of the HCV NS5B polymerase.
Kumar DV; Rai R; Brameld KA; Riggs J; Somoza JR; Rajagopalan R; Janc JW; Xia YM; Ton TL; Hu H; Lehoux I; Ho JD; Young WB; Hart B; Green MJ
Bioorg Med Chem Lett; 2012 Jan; 22(1):300-4. PubMed ID: 22119470
[TBL] [Abstract][Full Text] [Related]
31. Identification of halosalicylamide derivatives as a novel class of allosteric inhibitors of HCV NS5B polymerase.
Liu Y; Donner PL; Pratt JK; Jiang WW; Ng T; Gracias V; Baumeister S; Wiedeman PE; Traphagen L; Warrior U; Maring C; Kati WM; Djuric SW; Molla A
Bioorg Med Chem Lett; 2008 Jun; 18(11):3173-7. PubMed ID: 18479921
[TBL] [Abstract][Full Text] [Related]
32. Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase.
Manfroni G; Meschini F; Barreca ML; Leyssen P; Samuele A; Iraci N; Sabatini S; Massari S; Maga G; Neyts J; Cecchetti V
Bioorg Med Chem; 2012 Jan; 20(2):866-76. PubMed ID: 22197397
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antiviral properties of novel 7-heterocyclic substituted 7-deaza-adenine nucleoside inhibitors of Hepatitis C NS5B polymerase.
Di Francesco ME; Avolio S; Pompei M; Pesci S; Monteagudo E; Pucci V; Giuliano C; Fiore F; Rowley M; Summa V
Bioorg Med Chem; 2012 Aug; 20(15):4801-11. PubMed ID: 22770556
[TBL] [Abstract][Full Text] [Related]
34. The design, synthesis and biological evaluations of C-6 or C-7 substituted 2-hydroxyisoquinoline-1,3-diones as inhibitors of hepatitis C virus.
Chen YL; Tang J; Kesler MJ; Sham YY; Vince R; Geraghty RJ; Wang Z
Bioorg Med Chem; 2012 Jan; 20(1):467-79. PubMed ID: 22100256
[TBL] [Abstract][Full Text] [Related]
35. Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors.
Herlihy KJ; Graham JP; Kumpf R; Patick AK; Duggal R; Shi ST
Antimicrob Agents Chemother; 2008 Oct; 52(10):3523-31. PubMed ID: 18694956
[TBL] [Abstract][Full Text] [Related]
36. PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication.
Lam AM; Murakami E; Espiritu C; Steuer HM; Niu C; Keilman M; Bao H; Zennou V; Bourne N; Julander JG; Morrey JD; Smee DF; Frick DN; Heck JA; Wang P; Nagarathnam D; Ross BS; Sofia MJ; Otto MJ; Furman PA
Antimicrob Agents Chemother; 2010 Aug; 54(8):3187-96. PubMed ID: 20516278
[TBL] [Abstract][Full Text] [Related]
37. Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors.
Mish MR; Cho A; Kirschberg T; Xu J; Zonte CS; Fenaux M; Park Y; Babusis D; Feng JY; Ray AS; Kim CU
Bioorg Med Chem Lett; 2014 Jul; 24(14):3092-5. PubMed ID: 24907145
[TBL] [Abstract][Full Text] [Related]
38. Discovery of N-arylalkyl-3-hydroxy-4-oxo-3,4-dihydroquinazolin-2-carboxamide derivatives as HCV NS5B polymerase inhibitors.
Deore RR; Chen GS; Chang PT; Chern TR; Lai SY; Chuang MH; Lin JH; Kung FL; Chen CS; Chiou CT; Chern JW
ChemMedChem; 2012 May; 7(5):850-60. PubMed ID: 22383290
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and anti-HCV activity of 3',4'-oxetane nucleosides.
Chang W; Du J; Rachakonda S; Ross BS; Convers-Reignier S; Yau WT; Pons JF; Murakami E; Bao H; Steuer HM; Furman PA; Otto MJ; Sofia MJ
Bioorg Med Chem Lett; 2010 Aug; 20(15):4539-43. PubMed ID: 20580554
[TBL] [Abstract][Full Text] [Related]
40. A cell-based assay for RNA synthesis by the HCV polymerase reveals new insights on mechanism of polymerase inhibitors and modulation by NS5A.
Ranjith-Kumar CT; Wen Y; Baxter N; Bhardwaj K; Cheng Kao C
PLoS One; 2011; 6(7):e22575. PubMed ID: 21799903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]